New appointment at Piedmont Pharmaceuticals
This article was originally published in Scrip
Executive Summary
Piedmont Pharmaceuticals (US), a speciality pharmaceutical company focused on parasitology and drug delivery systems for human and companion animal use, has appointed Eric Barnett executive vice-president of business development and marketing. During his eight years on the clinical executive committee at GlaxoSmithKline, he led the capital management of the global R&D clinical portfolio.